StockData
Arcadia Biosciences, Inc. logo

Arcadia Biosciences, Inc. (RKDA) stock

RKDANasdaqBeveragesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/30
$0.19−0.00 (-2.01%)

Close on Nov 17, 2026Market cap $457.03KP/E –Yield –

Arcadia Biosciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Arcadia Biosciences's total debt was $0 at Dec 31, 2021. For fiscal 2021 it was $0, down 100.0% from the year before. The highest annual figure on record is $25.13M in fiscal 2016.

Annual total debt

PeriodPeriod endValueChange
FY2021Dec 31, 2021$0-100.0%
FY2020Dec 31, 2020$3.25M+2377.9%
FY2019Dec 31, 2019$131.00K-99.5%
FY2016Dec 31, 2016$25.13M+0.8%
FY2015Dec 31, 2015$24.93M+151.2%
FY2014Dec 31, 2014$9.92M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2021Dec 31, 2021$0-100.0%
Q3 FY2021Sep 30, 2021$114.00K-96.5%
Q2 FY2021Jun 30, 2021$1.23M-62.4%
Q1 FY2021Mar 31, 2021$1.24M+851.5%
Q4 FY2020Dec 31, 2020$3.25M+2377.9%
Q3 FY2020Sep 30, 2020$3.25M+2778.8%
Q2 FY2020Jun 30, 2020$3.26M-87.1%
Q1 FY2020Mar 31, 2020$130.00K-99.5%
Q4 FY2019Dec 31, 2019$131.00K-99.5%
Q3 FY2019Sep 30, 2019$113.00K-99.5%
Q2 FY2017Jun 30, 2017$25.23M–
Q1 FY2017Mar 31, 2017$25.18M–
Q4 FY2016Dec 31, 2016$25.13M–
Q3 FY2016Sep 30, 2016$25.08M–

More Arcadia Biosciences figures

See a number that looks wrong?